IHS Chemical Week

World News and Views :: Projects

NPIL Pharma to Expand Capacity

2:10 PM MDT | October 15, 2007 | DR

NPIL Pharma, the custom manufacturing division of Nicholas Piramal India Ltd. (NPIL; Mumbai), says it will invest about $4 million in its early phase pharma development and scale-up (PDS) facility at Chennai, southern India. NPIL is India’s fourth-largest pharmaceutical company. NPIL says it will add eight new reactors with 12,000 liters of capacity to its Chennai cGMP plant by year-end. New facilities will be installed for manufacturing final active pharmaceutical ingredients (API), with a clean room for final API powder processing and packing. A new...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa